Quest Diagnostics to close more laboratories:
This article was originally published in Clinica
The largest clinical laboratory company in the US, Quest Diagnostics, will close or scale down seven labs across the US and shed between 1,250 and 2,500 workers over the next 18 months as it integrates the SmithKline Beecham Clinical Labs acquisition (see Clinica No 846, p 1). The labs which are being downgraded are in markets where the company has duplication. In addition, esoteric testing currently conducted in Van Nuys, California, will move to Quest's Nichols Institute in San Juan Capistrano, California.
You may also be interested in...
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.